Quantum Computing partners with INmune Bio to apply quantum optimization, AI in Alzheimer’s drug research
Bitget2026/10/14 12:33- Quantum Computing entered a collaboration with INmune Bio to apply quantum optimization, AI, and analytics to Alzheimer’s drug research.
- Work will use QCi’s Dirac-3S quantum optimization machine to identify new indications and biomarkers for INmune Bio’s XPro (XPro1595).
- Project will analyze INmune Bio clinical-trial data alongside public biomedical datasets to prioritize patient groups and potential disease targets.
- Engagement is QCi’s first commercial customer deal in pharma and biotech, expanding its quantum computing applications into drug development.
- Program will benchmark quantum optimization results against conventional statistical and machine-learning methods to assess where quantum adds value.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic spends $3.4 billion to purchase gas-fired power equipment to supply electricity for data centers
In September, Anthropic directly acquired Caterpillar equipment orders worth 3.4 billion USD, securing 1.7 GW of gas generator units, marking the largest single purchase of power generation equipment in AI history. This move bypassed utility middlemen, capturing scarce capacity at prices set years ago with near-term delivery. It is part of Anthropic's plan to invest over 895 billion USD in computing infrastructure by 2045.

Why Nintendo Stock Is One to Watch Ahead of the Holiday Season

A wallet address sold 1.44 million TRX via SunSwap in exchange for 460,000 USDT.

Data: Whales have cumulatively withdrawn approximately 13.4 million USDT from a certain exchange.